June 30, 2014 / 12:50 PM / 3 years ago

BUZZ-Dicerna Pharmaceuticals Inc: Promising animal trial data

** Drug developer’s shares up 13 pct at $21.35 premarket

** Company presents positive preclinical data on its experimental liver disease drug

** The animal trials showed that Dicerna’s drug blocked a gene that is found in patients with a rare inherited liver disorder called PH1

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below